New ACE2 (human) ELISA Kit

New ACE2 (human) ELISA Kit

AdipoGen Life Sciences has developed a sensitive and specific colourimetric sandwich ACE2 (human) ELISA Kit (Prod. No. AG-45B-0023) that can be used for the in vitro quantitative determination of soluble human ACE2 in cell culture supernatants, serum, plasma and urine.

ACE2 has been identified as a key receptor on target cells for SARS-CoV infections in 2002. ACE2 functions as the entry receptor of the new SARS-CoV-2 coronavirus that emerged in China in 2019 and is the cause of the new disease COVID-19. Strong binding of the spike protein of SARS-CoV-2 to ACE2, along with proteolytic cleavage of ACE2 by transmembrane serine protease 2 (TMPRSS2), facilitates entry of the virus into cells, viral replication and cell-to-cell transmission. ACE2 can undergo an ADAM17 (a disintegrin and metalloproteinase 17)-mediated “shedding” from endothelial cells, resulting in the release of the ectodomain into the circulation. This soluble form may act as a competitive interceptor of SARS-CoV-2 and other coronaviruses by preventing the binding of the viral particle to the surface-bound, full-length ACE2. A reliable ELISA Kit to determine soluble ACE2 in the circulation can be useful in therapeutic developmental studies.

Soluble ACE2 might also be used as a biomarker of hypertension and cardiovascular diseases.

Figure: Typical Standard Curve

Originally posted on adipogen.com/covid-19

Caltag Medsystems is the distributor of Adipogen products in the UK and Ireland. If you have any questions about these products, please contact us.

New ACE2 (human) ELISA Kit
Tagged on:         

Contact us